WTC
GSK icon

WhitTier Trust Company’s GSK GSK Stock Holding History

WhitTier Trust Company’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,190
Closed -$84.1K – 1374
2025
Q2 		$84.1K Sell
2,190
-43
-2% -$1.64K ﹤0.01% 663
2025
Q1 		$86.5K Hold
2,233
– – ﹤0.01% 643
2024
Q4 		$75.5K Buy
2,233
+417
+23% +$15K ﹤0.01% 659
2024
Q3 		$74.2K Buy
1,816
+6
+0.3% +$245 ﹤0.01% 663
2024
Q2 		$69.7K Sell
1,810
-415
-19% -$17.5K ﹤0.01% 632
2024
Q1 		$95.4K Buy
2,225
+20
+0.9% +$825 ﹤0.01% 567
2023
Q4 		$81.7K Sell
2,205
-744
-25% -$26.7K ﹤0.01% 594
2023
Q3 		$107K Sell
2,949
-113
-4% -$4.01K ﹤0.01% 539
2023
Q2 		$109K Buy
3,062
+393
+15% +$14.1K ﹤0.01% 555
2023
Q1 		$94.9K Buy
2,669
+219
+9% +$7.66K ﹤0.01% 567
2022
Q4 		$86.1K Sell
2,450
-3
-0.1% -$100 ﹤0.01% 580
2022
Q3 		$72K Sell
2,453
-236
-9% -$8.94K ﹤0.01% 613
2022
Q2 		$146K Buy
2,689
+161
+6% +$8.89K 0.01% 500
2022
Q1 		$138K Hold
2,528
– – 0.01% 518
2021
Q4 		$139K Buy
2,528
+584
+30% +$30.4K 0.01% 516
2021
Q3 		$93K Buy
1,944
+678
+54% +$34.1K ﹤0.01% 570
2021
Q2 		$63K Buy
1,266
+73
+6% +$3.51K ﹤0.01% 622
2021
Q1 		$53K Sell
1,193
-656
-35% -$29.8K ﹤0.01% 630
2020
Q4 		$85K Buy
1,849
+139
+8% +$6.38K ﹤0.01% 531
2020
Q3 		$80K Buy
1,710
+174
+11% +$8.72K ﹤0.01% 530
2020
Q2 		$78K Sell
1,536
-105
-6% -$5.39K ﹤0.01% 517
2020
Q1 		$78K Buy
1,641
+228
+16% +$12.2K 0.01% 495
2019
Q4 		$83K Buy
1,413
+333
+31% +$18.5K 0.01% 519
2019
Q3 		$58K Hold
1,080
– – ﹤0.01% 567
2019
Q2 		$54K Hold
1,080
– – ﹤0.01% 573
2019
Q1 		$56K Sell
1,080
-252
-19% -$12.6K ﹤0.01% 569
2018
Q4 		$64K Sell
1,332
-148
-10% -$7.29K 0.01% 532
2018
Q3 		$74K Hold
1,480
– – 0.01% 546
2018
Q2 		$75K Sell
1,480
-688
-32% -$34.7K 0.01% 539
2018
Q1 		$106K Sell
2,168
-80
-4% -$3.73K 0.01% 476
2017
Q4 		$100K Sell
2,248
-800
-26% -$37K 0.01% 464
2017
Q3 		$155K Buy
3,048
+107
+4% +$5.43K 0.01% 369
2017
Q2 		$158K Hold
2,941
– – 0.02% 362
2017
Q1 		$155K Sell
2,941
-1,040
-26% -$52.8K 0.02% 364
2016
Q4 		$192K Sell
3,981
-800
-17% -$39.5K 0.02% 342
2016
Q3 		$257K Sell
4,781
-455
-9% -$24.9K 0.03% 310
2016
Q2 		$284K Hold
5,236
– – 0.03% 301
2016
Q1 		$265K Hold
5,236
– – 0.03% 304
2015
Q4 		$264K Sell
5,236
-80
-2% -$4.08K 0.03% 307
2015
Q3 		$256K Sell
5,316
-80
-1% -$4.16K 0.03% 313
2015
Q2 		$281K Hold
5,396
– – 0.03% 317
2015
Q1 		$311K Hold
5,396
– – 0.03% 309
2014
Q4 		$288K Sell
5,396
-520
-9% -$29.1K 0.03% 314
2014
Q3 		$340K Hold
5,916
– – 0.04% 281
2014
Q2 		$395K Sell
5,916
-880
-13% -$59.6K 0.04% 265
2014
Q1 		$454K Hold
6,796
– – 0.05% 248
2013
Q4 		$453K Buy
6,796
+200
+3% +$13K 0.05% 237
2013
Q3 		$414K Sell
6,596
-1,360
-17% -$87.5K 0.06% 237
2013
Q2 		$496K Buy
+7,956
New +$505K 0.07% 209

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WhitTier Trust Company's GSK Position: Q3 2025 in Review

WhitTier Trust Company sold out of GSK (GSK) in Q3 2025, closing a stake of 2,190 shares — an estimated $84.1K sold.

WhitTier Trust Company first reported a position in GSK in Q2 2013 and held it in 49 quarters. The position peaked at $496K in Q2 2013. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • WhitTier Trust Company reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
  • WhitTier Trust Company sold 2,190 GSK shares in Q3 2025, an estimated $84.1K.
  • WhitTier Trust Company first reported a position in GSK in Q2 2013 and held it in 49 quarters.
  • WhitTier Trust Company's GSK position peaked at $496K in Q2 2013.
  • 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on WhitTier Trust Company's 13F filing for Q3 2025, filed 31 Oct 2025.